Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Emilio Rivolta is active.

Publication


Featured researches published by Emilio Rivolta.


Nephron | 1985

Hypertension in Man with a Kidney Transplant: Role of Familial versus Other Factors

Ettore Guidi; Giuseppe Bianchi; Emilio Rivolta; Claudio Ponticelli; Filippo Quarto di Palo; L. Minetti; Elio Polli

Genetic factors are clearly involved in the pathogenesis of essential hypertension in man. In at least three rat models of genetic hypertension it is possible to transplant the hypertension with the kidney. To see whether or not the same is true for humans, we carried out a 2-year retrospective study of 50 selected recipients of a cadaver kidney. We correlated the following factors by multivariate statistical analyses: presence or absence of hypertension in the family of donor and recipients; donors and recipients age; mean blood pressure (MBP) and antihypertensive therapy (AHT) score during dialysis; months of dialysis and body surface before transplantation; body weight, plasma creatinine, prednisone dosage and cumulative rejections with MBP and AHT score at various time intervals after transplantation. The results obtained showed that, considering the recipients coming from normotensive families, the AHT score after transplantation was significantly greater (p less than 0.05 1st and p less than 0.01 2nd year) in the patients receiving a kidney removed from donors with hypertensive families than in patients receiving a kidney removed from donors with normotensive families. This difference was not present when the recipients coming from hypertensive parents were considered. AHT score after transplantation is also correlated with AHT score on dialysis (p less than 0.01 1st and 2nd year), body weight (p less than 0.02 1st and p less than 0.01 2nd year), cumulative rejections (p less than 0.025 1st and 2nd year) and inverse MBP after dialysis (p less than 0.025 2nd year).


Transplantation | 1983

De novo focal glomerular sclerosis in an identical twin renal transplant recipient

Emilio Rivolta; Claudio Ponticelli; Imbasciati E; Antonio Vegeto

A patient with end-stage renal failure caused by bilateral kidney stones received a kidney transplant from his identical twin. No immunosuppressive therapy was given. After a few days he developed a urinary fistula from a polar artery section, which spontaneously healed. Renal function remained subnormal, blood pressure and urinalysis were normal. After one year proteinuria appeared, and after about four years it entered a nephrotic range. Renal biopsy showed focal glomerular sclerosis (FGS). In the following years progressive renal insufficiency and arterial hypertension developed, and the patient had to be submitted to regular dialysis about 9 years after transplantation. As far as we know this is the first case of late renal failure in an isograft related to the development of de novo FGS. It is suggested that de novo FGS in this isotransplant was related to the partial loss of renal mass caused by polar necrosis, which caused glomeralar hyperfiltration. Another possible contributing factor may be kidney denervation, which removes an important mechanism for adjustment of renal arterial flow.


American Journal of Nephrology | 1990

Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis

Claudio Ponticelli; Emilio Rivolta

Results of the available literature and preliminary data of an ongoing multicenter, prospective, randomized Italian trial indicate that ciclosporin (CS), at low doses, may maintain remission of the nephrotic syndrome in most steroid-sensitive patients. In steroid-resistant patients CS may cause either complete or partial remission in about 40% of patients with idiopathic nephrotic syndrome. With doses not exceeding 5 mg/kg/day and careful monitoring of renal and liver function, blood pressure and blood levels, severe side effects can be prevented. Although an extensive use of CS in nephrotic syndrome is still premature, cautious trials may be attempted in patients with steroid toxicity and/or devastating nephrotic syndrome.


Pediatric Nephrology | 1996

Nephrotic syndrome in a mother and her infant: relationship with cytomegalovirus infection.

Marisa Giani; Alberto Edefonti; Beatrice Damiani; Giuseppina Marra; Daniela Colombo; Giovanni Banfi; Emilio Rivolta; Erich H. Strøm; Michael J. Mihatsch

This case report describes infantile nephrotic syndrome (NS) in a baby girl with a clinically severe cytomegalovirus (CMV) infection. Culture of the babys urine was positive for CMV and IgM anti-CMV antibodies were detected. After an unsuccessful course of corticosteroids, gancyclovir treatment was started and a remission of cutaneous, pulmonary, and renal symptoms was achieved. As the mother also developed NS at the end of pregnancy, a common etiology could be postulated, although there were no signs of recent CMV infection in the mother, only anti-CMV IgG. The relationship between CMV infection and glomerular disease is still unclear: NS may represent another manifestation of CMV disease.


Nephron | 1985

Controlled Trial of Two Different Methylprednisolone Doses in Cadaveric Renal Transplantation

A. De Vecchi; Emilio Rivolta; Antonio Tarantino; F. Egidi; L. Berardinelli; A. Vegeto; Claudio Ponticelli

In a controlled trial the effects of two different methylprednisolone (MP) schedules were studied in 100 cadaver kidney adult recipients followed for 18-46 months. Group A patients were given 160 mg/day i.v. for 3 days, then oral MP (0.8 mg/kg/day), which was tapered by 4 mg/week to a maintenance dose of 16 mg/day up to the 6th month. Group B patients were given 80 mg/day i.v. for 3 days followed by 0.4 mg/kg/day oral MP; the dose was reduced by 2 mg/week to 16 mg/day. In both groups, the dose was further reduced bimonthly to a final dose of 8 mg/day. No significant differences were evidenced between the two groups in patients and kidney survival or in the incidence of complications. The number of patients with at least one rejection episode was significantly higher in the lower dose group.


Nephron | 1974

Albumin and α-2-Macroglobulin Clearance: A New Approaching Method for Studying Selectivity of Proteinuria in Unconcentrated Urine

Diego Brancaccio; Emilio Rivolta; G. Graziani; M. Pizzolato

The possibility of evaluating albumin and α-2 macroglobulin clearances has been investigated, on unconcentrated urine samples, using a sensitive method (Laurell’s ‘rocket’ electrophoresis on cellulose acetate gel) in order to assess its adaptability in clinical practice.In 37 patients, presenting glomerular proteinuria, Cl α-2-M/Cl Alb. and Cl IgG/Cl Transf. have been compared. The correlation is satisfactory in all histological groups considered, with the interesting exception of focal glomerulosclerosis and amyloidosis.


Kidney International | 1993

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome

Claudio Ponticelli; Gianfranco Rizzoni; Alberto Edefonti; Paolo Altieri; Emilio Rivolta; Stefano Rinaldi; Luciana Ghio; Egidio Lusvarghi; Rosanna Gusmano; Francesco Locatelli; Sonia Pasquali; Alfonso Castellani; Ornella Della Casa-Alberighi


Nephrology Dialysis Transplantation | 2006

Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up

Gabriella Moroni; Beniamina Gallelli; Silvana Quaglini; Giovanni Banfi; Emilio Rivolta; Piergiorgio Messa; Claudio Ponticelli


JAMA Internal Medicine | 1980

Hemolytic Uremic Syndrome in Adults

Claudio Ponticelli; Emilio Rivolta; Imbasciati E; Edoardo Rossi; Pier Mannuccio Mannucci


American Journal of Kidney Diseases | 1998

Glomerulonephritis associated with myasthenia gravis

Giorgio Valli; Giovanni B. Fogazzi; A. Cappellari; Emilio Rivolta

Collaboration


Dive into the Emilio Rivolta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge